About the project
ENABLE (European Academy for Biomedical Science) is an initiative funded by the European Union Horizon 2020 programme that involves four renowned European Research Institutes (IRB Barcelona – Spain, RIMLS – Netherlands, NNF CPR – Denmark, SEMM – Italy) and an innovative science communication agency (Scienseed).
ENABLE seeks to promote excellence in the biomedical sciences in Europe: supporting young researchers, strengthening scientific careers, and bringing biomedicine closer to society.
Until 2021, four European cities will host annually a 3-day international congress on biomedicine organised by and for young biomedical scientists: Barcelona 2017, Copenhagen 2018, Nijmegen 2019, Milan 2021.
The partners
IRB Barcelona is a world-class research center devoted to understanding fundamental questions about human health and disease. It was founded in October 2005 by the Government of Catalonia and the University of Barcelona.
The Institute’s missions include conducting multidisciplinary research of excellence at the unique interface between biology, chemistry and medicine, providing high-level training in the biomedical sciences to staff, students and visitors, driving innovation through active technology transfer to the benefit of society, and actively participating in an open dialogue with the public through a series of engagement and education activities.
The mission of the Radboud Institute for Molecular Life Sciences (RIMLS) is to achieve a greater understanding of the molecular mechanisms of disease.
By integrating fundamental and clinical research, the institute obtains multifaceted knowledge of (patho)physiological processes. To have a significant impact on healthcare, these findings are translated into diagnostics, therapeutics and personalized treatment strategies.
The multi-disciplinary approach to research in molecular life science is reflected in an established RIMLS Graduate School with a dedicated 2-year research honours MSc degree in Molecular Mechanisms of Disease and a follow-up 4-year PhD program.
Novo Nordisk Foundation Center for Protein Research (CPR) was established at the Faculty of Health and Medical Sciences, University of Copenhagen to promote basic and applied discovery research on human proteins of medical relevance. CPR aims to assemble protein-related technologies with revolutionary potential for understanding the complex wiring of biological systems and disease processes.
The vision of the Center is to be the world’s leading center in integrative protein technologies and their application to accelerate understanding of the biological processes underlying health and disease.
This is achieved by developing integrated protein technology platforms and management systems for large heterogeneous data to advance the understanding of complex protein networks in fundamental biology and disease, educating the next generation of top-tier protein scientists and becoming an unmatched global partner in protein research.
SEMM is a private foundation established in 2001 by a joint ministerial decree of three Italian Ministries, Health, Treasure, and Education, Scientific and Technological Research. The mission of the Scuola Europea di Medicina Molecolare (SEMM) is to promote the training and research of young scientists within emerging sectors of biomedicine.
SEMM operates within research centers of excellence bridging together higher education and front-line research training. Science covers virtually every aspect of modern Cell Biology and Molecular Biology, both from the basic and applied research points of view.
SEMM manages in agreement with the University of Milan and Naples, a PhD program in Systems Medicine which includes 5 curricula: Molecular Oncology, Human Genetics, Computational Biology, Medical Nanotechnology and Foundations of the Life Sciences Bioethics and Cognitive Sciences and a post doc program SIPOD.
Founded in 1964, The Federation of European Biochemical Societies (FEBS) has become one of Europe’s largest organizations in the molecular life sciences, with over 35,000 members across more than 35 biochemistry and molecular biology societies (its ‘Constituent Societies’) in different countries of Europe and neighbouring regions.
As a charity, FEBS promotes and supports biochemistry, molecular biology, cell biology, molecular biophysics and related research areas through its journals, Congress, Advanced Courses, Fellowships and other initiatives.
There is an emphasis in many programmes on scientific exchange and cooperation between scientists working in different countries, and on promotion of the training of early-career scientists. Information about FEBS is available at www.febs.org.
The International Union of Biochemistry and Molecular Biology – founded in 1955 – unites biochemists and molecular biologists in 79 countries and regions that belong to the Union as an Adhering Body or Associate Adhering Body represented by a biochemical society, a national research council or an academy of sciences.
The Union is devoted to promoting research and education in biochemistry and molecular biology throughout the world and gives particular attention to providing opportunities to students, postdoctoral fellows, and junior investigators to advance their training.
It achieves this by offering numerous fellowships for research, education, and meetings as described in this article. Information about IUBMB is available at www.iubmb.org.
Hosting institutions
The Institute of Biomedicine of Seville (IBiS), was created in 2006 as a multidisciplinary biomedical research centre within the complex that houses the Virgen del Rocío University Hospital, a centre of high-level care, education and research.
Its principal objective is to undertake competitive research at an international level on the causes of the most prevalent pathologies in the population, and to develop new methods for their diagnosis and treatment.
IBiS is based on fundamental research at the molecular and cellular level with a view to promote the rapid transfer of knowledge to the clinical setting, at the same time improving the quality of clinical and epidemiological research.
Funding